American Portfolios Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.58K Hold
300
﹤0.01% 3046
2022
Q2
$2.44K Sell
300
-334
-53% -$3.19K ﹤0.01% 3082
2022
Q1
$7.7K Hold
634
﹤0.01% 2789
2021
Q4
$21.6K Hold
634
﹤0.01% 2286
2021
Q3
$30.6K Hold
634
﹤0.01% 2048
2021
Q2
$28.6K Hold
634
﹤0.01% 2030
2021
Q1
$30.6K Buy
+634
New +$33K ﹤0.01% 1834
2020
Q4
Sell
-634
Closed -$23.4K 3066
2020
Q3
$23.4K Hold
634
﹤0.01% 1634
2020
Q2
$19.6K Buy
634
+300
+90% +$8.31K ﹤0.01% 1646
2020
Q1
$9.22K Buy
+334
New +$10K ﹤0.01% 1847

Other funds holding NEO

American Portfolios Advisors's NEO Position: Q3 2022 in Review

American Portfolios Advisors held its NeoGenomics (NEO) position steady in Q3 2022 at 300 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #3046.

American Portfolios Advisors first reported a position in NEO in Q1 2020 and has held it in 10 quarters since. The position peaked at $30.6K in Q3 2021. 247 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

  • American Portfolios Advisors held 300 shares of NeoGenomics worth $2.58K as of Q3 2022.
  • American Portfolios Advisors left its NeoGenomics share count unchanged in Q3 2022.
  • NeoGenomics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3046 holding.
  • American Portfolios Advisors first reported a position in NeoGenomics in Q1 2020 and has held it in 10 quarters since.
  • American Portfolios Advisors's NeoGenomics position peaked at $30.6K in Q3 2021.
  • 247 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.